Soydan Ekin, Gonullu Ahmet, Aksoy Yigit, Guzin Yigithan, Ceylan Gokhan, Topal Sevgi, Colak Mustafa, Hepduman Pınar, Sandal Ozlem Sarac, Atakul Gulhan, Karaarslan Utku, Unalp Aycan, Apa Hurşit, Agın Hasan
Pediatric Intensive Care Unit, Dr. Behcet Uz Children's Diseases and Surgery Training and Research Hospital, University of Health Sciences, Izmir, Turkey.
Department of Pediatric Emergency, Dr. Behcet Uz Children's Hospital, University of Health Sciences, Izmir, Turkey.
J Child Neurol. 2022 Dec;37(12-14):956-962. doi: 10.1177/08830738221125424. Epub 2022 Sep 21.
To prospectively investigate the predictive value of the modified Status Epilepticus Severity Score (STESS) for pediatric use (STEPSS) regarding unfavorable outcomes in the short term. Patients diagnosed as status epilepticus in the emergency department between January 2019 and June 2021 at a tertiary center of the University of Health Sciences, Dr. Behcet Uz Children's Hospital, were included in the study. The patients were followed up in the emergency department, neurology clinic, and pediatric intensive care unit until discharge. Demographic and clinical characteristics, STEPSS, and Pediatric Overall Performance Category Scale (POPC) scores were calculated. We defined a Pediatric Overall Performance Category Scale score ≥3 as an unfavorable outcome. We compared the effect of STEPSS on unfavorable outcomes and mortality. 124 children were included. The median age was 33 months (interquartile range 16.2-84.7). Seventy-two (58.1%) patients had acute symptomatic etiology. We found that the STEPSS score with the receiver operating characteristic curve (area under the curve = 0.917, < .001) could predict unfavorable outcomes (Pediatric Overall Performance Category Scale score ≥3) in children with status epilepticus. The Youden index (0.76) showed that a STEPSS score >2 was the optimal cutoff point for an unfavorable outcome. We found STEPSS useful in predicting mortality (area under the curve = 0.853, < .001). The Youden index (0.58) indicated that a STEPSS >2 was the optimal cutoff for mortality: sensitivity 0.90 (95% confidence interval [CI] 0.58-0.99), specificity 0.67 (95% CI 0.57-0.77), positive predictive value 0.21, negative predictive value 0.98, positive likelihood ratio 2.7, negative likelihood ratio 0.14. We determined that STEPSS can be predicted unfavorable outcomes and mortality. We think that STEPSS can be used as a useful clinical score with further studies and external validations.
前瞻性研究改良的儿童癫痫持续状态严重程度评分(STEPSS)对小儿短期不良预后的预测价值。纳入2019年1月至2021年6月在健康科学大学三级中心贝赫切特·乌兹儿童医院急诊科诊断为癫痫持续状态的患者。患者在急诊科、神经科门诊和儿科重症监护病房接受随访直至出院。计算人口统计学和临床特征、STEPSS以及儿科总体表现类别量表(POPC)评分。我们将儿科总体表现类别量表评分≥3定义为不良预后。比较STEPSS对不良预后和死亡率的影响。共纳入124名儿童。中位年龄为33个月(四分位间距16.2 - 84.7)。72名(58.1%)患者有急性症状性病因。我们发现,通过受试者工作特征曲线得出的STEPSS评分(曲线下面积=0.917,P<0.001)可预测癫痫持续状态儿童的不良预后(儿科总体表现类别量表评分≥3)。约登指数(0.76)表明,STEPSS评分>2是不良预后的最佳截断点。我们发现STEPSS对预测死亡率有用(曲线下面积=0.853,P<0.001)。约登指数(0.58)表明,STEPSS>2是死亡率的最佳截断值:敏感性0.90(95%置信区间[CI]0.58 - 0.99),特异性0.67(95%CI 0.57 - 0.77),阳性预测值0.21,阴性预测值0.98,阳性似然比2.7,阴性似然比0.14。我们确定STEPSS可预测不良预后和死亡率。我们认为,经过进一步研究和外部验证后,STEPSS可作为一个有用的临床评分。